venBio Global Strategic Fund II L.P., 10% Owner at Akero Therapeutics, Inc. (AKRO), sold 232,934 shares at $33.83 ($8.0M) on 2020-07-06, disclosed to the SEC on 2020-07-06.
Open-market sale of $8.0M AKRO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.45 | 108,064 | $3.7M | 46.5% |
| 2 | $34.45 | 108,064 | $3.7M | 46.5% |
| 3 | $33.63 | 3,800 | $128K | 1.6% |
| 4 | $33.63 | 3,800 | $128K | 1.6% |
| 5 | $33.83 | 4,603 | $156K | 1.9% |
| 6 | $33.83 | 4,603 |
| $156K |
| 1.9% |
| Total | $34.40 avg | 232,934 | $8.0M | 100% |
| Filing → |
| CMPI | SELL | 2022-04-29 | $3.2M | — | Filing → |
| IMPL | BUY | 2021-04-29 | $6.8M | — | Filing → |
| AKRO | SELL | 2020-02-10 | $330K | — | Filing → |